| INTRODUC TI ON
Alloimmunity is characterized by the expansion and differentiation of CD4 + T cells into effector (Teff) and/or memory subsets in response to donor alloantigen. 1 However, the simultaneous expansion of alloantigen-responsive CD4 + Foxp3 + T regulatory cells (Tregs) controls effector immunity, and recent findings indicate that relative Treg activity may inhibit the progression of allograft rejection. 2, 3 Indeed, enhancing signals and events that promote CD4 + Treg expansion, function, and/ or subset stability has emerged as a key area for future therapeutic development. 4, 5 Thus, insights into mechanisms of CD4 + Foxp3 + Treg cell function are of great significance in the field of transplantation.
Multiple studies indicate that the mechanistic target of rapamycin (mTOR) kinase functions in CD4 + T cell activation responses, protein translation, and cellular metabolism to augment proliferation, differentiation, and survival of Teff subsets. [6] [7] [8] [9] [10] Importantly, mTOR signaling activity negatively regulates Foxp3 expression in CD4 + T cells 11 and inhibits Treg cell differentiation, metabolism, and function. 6, 9 Indeed, the inhibition and/or control of mTOR activity is currently established to result in the expansion and enhanced function of CD4 + Treg cells. 11, 12 mTOR is a serine/ threonine kinase that serves as a critical sensor of cellular energy status 13, 14 and as an intermediary in diverse intracellular signaling responses. [6] [7] [8] [9] [15] [16] [17] [18] [19] It forms two distinct multiprotein complexes called mTORC1 20 and mTORC2, 21 characterized by the association between mTOR and the scaffold proteins raptor and rictor, respectively. In general, mTORC1 controls cell growth in part via the phosphorylation of S6K1 22 and 4E-BP1, 20 key regulators of protein synthesis, whereas mTORC2 modulates activation and cell survival by the phosphorylation of the Akt 21 and SGK 23 kinases.
mTORC1 and mTORC2 regulate glycolytic as well as oxidative metabolism 24, 25 inasmuch as the intensity of the signaling response is thought to be associated with increased aerobic glycolysis and fatty acid synthesis. 26 In contrast, low mTOR activity favors mitochondrial β-oxidation of free fatty acids and the inhibition of glucose utilization. 26 Nevertheless, despite its importance in CD4 + T cell biology and in cellular metabolism, little is known about the regulation of mTOR itself. However, there is increasing evidence that modulatory cell-intrinsic proteins are of biological significance in CD4 + T cell homeostasis. 7, 8, 18, 19 DEPTOR (Dishevelled, EGL-10, Pleckstrin [DEP]-domain containing mTOR interacting protein, also called DEPDC6 27 ) is an evolutionarily conserved mTOR-binding partner that was originally described to modulate mTOR signaling in multiple myeloma cells. 28 We previously identified a potent function for DEPTOR within vascular endothelial cells, 29 and it has been found to function in several other normal cell types including adipose tissue, myocytes, and hepatocytes. [30] [31] [32] DEPTOR is rapidly phosphorylated and targeted for ubiquitination and degradation following cellular activation, 33 suggesting that it may function to sustain cellular quiescence and/or to regulate mTORC1/C2 interactions.
In this study, we find that DEPTOR is expressed by CD4 + T cells and that its level of expression is reduced upon cellular activation. In addition, we find that sustained expression of CD4 + T cell DEPTOR 
| MATERIAL S AND ME THODS

| Mice
Male 6-to 8-week-old C57BL/6 (H- mice as a control for analyses performed using DEP and iDEP mice.
| Treg-specific demethylated region methylation analysis
Fluorescence activated cell sorting (FACS) was used to separate and sort cells, which were pelleted, frozen, and processed for pyrosequencing by EpigenDx (Hopkinton, MA). Briefly, genomic DNA was isolated and modified with bisulfite. All 14 CpG islands within the promoter and intron 1 of the Foxp3 gene were amplified by polymerase chain reaction (PCR) and pyrosequenced. Sequences were aligned to a reference mouse genome database and the percentage of converted (demethylated) cytosine to uracil/thymidine for each CpG site was determined.
| Cardiac and skin transplantation
Heterotopic intraabdominal cardiac transplantation was performed as described by Corry et al. 35 Following transplantation, graft survival was monitored by palpation of the heartbeat. Tail skin grafts were transplanted onto the thoracic wall as described 36 
| Statistics
Statistical analyses were performed using the one-sample t test, two- 
| RE SULTS
| Expression of DEPTOR by CD4 + T cells
In initial studies, we observed that DEPTOR is expressed at high levels in unactivated wild type (WT) CD4 + T cells and that its mRNA and protein expression levels decreased upon mitogen-activation ( Figure 1A ). We also found that DEPTOR is readily visualized by immunofluorescence and confocal microscopy both within unactivated CD4 + T cells ( Figure 1B) Figure 1C-D) . In contrast, treatment of WT CD4 + T cells with dox failed to alter intrinsic DEPTOR expression patterns ( Figure   S1A ). By Western blot analysis ( Figure 1D ), we found reduced levels of pS6K(T389) and induced levels of pAkt (S473) We next fed DEP mice with dox chow ( Figure S1A ) and performed a time-dependent analysis of the resultant CD4 + T cell phenotype.
All mice remained physiologically normal, and the relative numbers As illustrated in Figure 4A and Figure S5A , we failed to observe any phenotypic differences by flow cytometry. However, by whole transcriptome RNA-sequencing (RNA-seq) we identified significant differences in the expression of 163 genes (adjusted P value 
| Sustained expression of DEPTOR in CD4 + T cells inhibits allograft rejection via the augmentation of Treg function in vivo
We next evaluated the function of CD4 + T cell DEPTOR in vivo using either WT C57BL/6 mice or DEP transgenics as recipients of fully MHC mismatched BALB/c heterotopic heart transplants. Groups of mice were fed with either control or dox chow for at least 1 week pretransplant and at all times posttransplant. As illustrated in Figure 5A , we found that dox treatment of WT recipients had no effect on graft survival; all grafts failed by day 7 posttransplant. In contrast, dox splenocytes and IFN-γ production was evaluated by ELISPOT. Bars represent the mean spots/well ± SD in 4 animals (n = 2 animals/group per experiment, performed twice in triplicate; Student's t test). (F) Serum from DEP/iDEP recipients on day 6 posttransplantation was evaluated for the production of donor-specific antibody using flow cytometry. Bar graphs represent the mean antibody titer ± SD (n = 4 animals/group; Student's t test)
in prolonged graft survival (MST 27 days, P < .01). We also transferred CD4 + CD25 high DEP or iDEP Tregs into ΔRag mice fed either control or dox chow, respectively, and we assessed the persistence Although all isografts were accepted, both donor and third-party skins were rejected ( Figure S6B ). Furthermore, we observed that the long-term surviving cardiac allografts were rejected within 2 days of donor skin graft rejection (data not shown). These data suggest that 
| D ISCUSS I ON
In these studies, we show that endogenous DEPTOR regulates Teff and Treg activity in vitro and in vivo, and we find that its relative level of expression is associated with shifts in cellular metabolism.
Notably, we find that sustained DEPTOR expression stabilizes CD4 Because DEPTOR regulates both mTORC1 and mTORC2 in CD4 + T cells, we had anticipated that sustained expression would inhibit Teff cell activation and differentiation, as described using rapamycin as well as genetic approaches that target mTORC1 activity. 9,10,37 Indeed, its effect to modulate Th2 and Th17 effector differentiation is consistent with these reports. However, our findings that increased DEPTOR expression fails to inhibit Th1 differentiation/activity or the activation of naive CD4 + T cells with anti-CD3 suggests that its biology is more complex. In summary, we identify DEPTOR as a cell intrinsic modulator of CD4 + T cell activation, and we show that its expression shapes metabolic programming to enhance immunoregulatory function.
Our findings have novel mechanistic implications in the control of alloimmunity and provide insight into the regulation of CD4 + Treg cell function that has broad biological significance in vivo.
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